Announcements Trials
Browse Landscape

Status

Completed 2

Sponsor Class

OTHER 2INDUSTRY 2

Study Type

Interventional 3Observational 2

Sponsor

Cancer Type

CNS 2

Conditions

Central Nervous System Neoplasms 2Central Nervous System Diseases 2

Interventions

Blood Specimen Collection 31Sorafenib 29Nivolumab 29Bevacizumab 26Data Collection 24Observation 23palbociclib 22Sunitinib 22radium Ra 223 dichloride 20enzalutamide 18Rituximab 18Ipilimumab 16regorafenib 15Drug Therapy 15Trastuzumab 14Docetaxel 14ribociclib 12exemestane 12atezolizumab 12Standard of Care 12darolutamide 11apalutamide 11Leuprolide 11Capecitabine 11Afatinib 11Bortezomib 10Anastrozole 10trastuzumab deruxtecan 9pembrolizumab 9avelumab 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
INDUSTRY × Observational × gadobenic acid × Clear all
NCT03147989 2018-07-18

Retrospective Study of MRI With MULTIHANCE at 0.10 and 0.05 mmol/Kg Dose in CNS Patients

Bracco Diagnostics, Inc

Completed
352 enrolled
CNS

Central Nervous System Diseases, Central Nervous System Neoplasms

NCT02291822 2016-07-19

Retrospective Study of MRI in Pediatric Patients

Bracco Diagnostics, Inc

Completed
90 enrolled
CNS

Central Nervous System Diseases, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡